Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs

Overview of attention for article published in Drug Safety, February 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

patent: 1 patent

Readers on

mendeley: 198 Mendeley

So far, Altmetric has seen 1 X post from an account with 96 followers.

Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs. https://t.co/ByULQaiK2d

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.